Sino Biological,Inc. (SHE:301047)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Recombinant Protein	273.11M
Recombinant Protein Growth	6.87%
Contract Research Organization Services	168.53M
Contract Research Organization Services Growth	9.40%
Antibody	106.49M
Antibody Growth	-41.20%
Culture Medium	28.23M
Culture Medium Growth	2.05%
Housing Rental and Supporting Facilities	26.38M
Housing Rental and Supporting Facilities Growth	70.84%
Gene	8.55M
Gene Growth	-27.35%
Other	2.38M
Other Growth	197.06%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Overseas	354.36M
Overseas Growth	-11.66%
China	259.31M
China Growth	5.72%